These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30232738)

  • 1. Metabolic and vascular effects of silybin in hypertensive patients with high 1-h post-load plasma glucose.
    Sciacqua A; Perticone M; Tripepi G; Addesi D; Cassano V; Maio R; Sesti G; Perticone F
    Intern Emerg Med; 2019 Jan; 14(1):77-84. PubMed ID: 30232738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients.
    Sciacqua A; Perticone M; Miceli S; Pinto A; Cassano V; Succurro E; Andreozzi F; Hribal ML; Sesti G; Perticone F
    Endocrine; 2019 Jun; 64(3):525-535. PubMed ID: 30790176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension.
    Sciacqua A; Maio R; Miceli S; Pascale A; Carullo G; Grillo N; Arturi F; Sesti G; Perticone F
    PLoS One; 2012; 7(9):e44470. PubMed ID: 23028545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and 1-hour post-load plasma glucose in hypertensive patients.
    Sciacqua A; Perticone M; Grillo N; Falbo T; Bencardino G; Angotti E; Arturi F; Parlato G; Sesti G; Perticone F
    Cardiovasc Diabetol; 2014 Feb; 13():48. PubMed ID: 24555478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients.
    Perticone M; Tassone EJ; Scarpino PE; Naccarato P; Addesi D; di Cello S; Sciacqua A; Maio R; Andreucci M; Carrao S; Licata A; Sesti G; Perticone F
    Acta Diabetol; 2016 Feb; 53(1):41-7. PubMed ID: 25813368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-hour post-load plasma glucose and IGF-1 in hypertensive patients.
    Perticone F; Sciacqua A; Tassone EJ; Miceli S; Maio R; Addesi D; Falbo T; Arturi F; Sesti G
    Eur J Clin Invest; 2012 Dec; 42(12):1325-31. PubMed ID: 23078161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterization of normotolerant hypertensive patients.
    Perticone F; Sciacqua A; Perticone M; Miceli S; Maio R; Tassone JE; Arturi F; Sesti G
    Int J Cardiol; 2013 May; 165(2):322-6. PubMed ID: 21925746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-hour post-load plasma glucose levels associated with decreased insulin sensitivity and secretion and early makers of cardiometabolic risk.
    Marcovecchio ML; Bagordo M; Marisi E; de Giorgis T; Chiavaroli V; Chiarelli F; Mohn A
    J Endocrinol Invest; 2017 Jul; 40(7):771-778. PubMed ID: 28255821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
    Trappoliere M; Federico A; Tuccillo C; de Sio I; Di Leva A; Niosi M; D'Auria M; Loguercio C;
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):193-9. PubMed ID: 15990709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients.
    Catena C; Colussi G; Frangipane A; Russo A; Verheyen ND; Sechi LA
    Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):968-74. PubMed ID: 26234565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and hypertension in postmenopausal women.
    Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.
    Bakris G; Molitch M; Hewkin A; Kipnes M; Sarafidis P; Fakouhi K; Bacher P; Sowers J;
    Diabetes Care; 2006 Dec; 29(12):2592-7. PubMed ID: 17130190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension in obese patients with heart hypertrophy. Effects of captopril on insulin sensitivity and growth hormone].
    Velasco-Cornejo IF; Martin LC; Brandão-Neto J; Marchioli M; de Barros e Silva M; Anthanázio-Heliodoro Rde C; Franco RJ da S
    Arq Bras Cardiol; 1995 Feb; 64(2):125-32. PubMed ID: 7575157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
    Federico A; Dallio M; Masarone M; Gravina AG; Di Sarno R; Tuccillo C; Cossiga V; Lama S; Stiuso P; Morisco F; Persico M; Loguercio C
    Oxid Med Cell Longev; 2019; 2019():8742075. PubMed ID: 31737175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
    Oksa A; Gajdos M; Fedelesová V; Spustová V; Dzúrik R
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary patterns and 1-h post-load glucose in essential hypertension.
    Sciacqua A; Perticone M; Falbo T; Grillo N; Tassone EJ; Sinopoli F; Lo Russo C; Succurro E; Andreozzi F; Sesti G; Perticone F
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):547-53. PubMed ID: 24462366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations.
    Federico A; Trappoliere M; Tuccillo C; de Sio I; Di Leva A; Del Vecchio Blanco C; Loguercio C
    Gut; 2006 Jun; 55(6):901-2. PubMed ID: 16698763
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of insulin sensitivity treatment with pioglitazone on endothelial function in non-diabetic patients with arterial hypertension.
    Schneider F; Vossler S; Franke S; Bär F; Konrad T
    Int J Clin Pharmacol Ther; 2009 May; 47(5):311-20. PubMed ID: 19473593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.